Conceptos Categóricos

Authors' Reports

James F. List
describes for SIIC the most significant aspects of his article
describe para SIIC los aspectos relevantes de su artículo


T2DM: DAPAGLIFLOZIN, METFORMIN XR, OR BOTH

In treatment-naïve patients with type 2 diabetes (T2D), initial combination therapy with dapagliflozin + extended-release metformin (MET XR) resulted in significant improvements in glycaemic and weight outcomes. Dapagliflozin + MET XR provided superior glycaemic benefits to monotherapy with either agent. The combination treatment was generally well tolerated.

The article was published by
El artículo fue publicado por
International Journal of Clinical Practice
Volume / Volumen: 66
Number / Número: 5
First and last pages / Páginas inicial-final: 446-456
Year / Año: 2012
Month / Mes: may


This journal, which is covered by SIIC Data Bases,
is part of the bibliographic collections of the Biblioteca Biomédica (BB) SIIC.
Esta revista, clasificada por SIIC Data Bases,
integra el acervo bibliográfico de la Biblioteca Biomédica (BB) SIIC.
icopagok.gif



Principal institution where the research took place
Institución principal de la investigación
Multiple sites in North America, Latin America, Europe, Asia. Address is not provided below, because there was no one principal institution., N/A, N/A, United States


a-livro3.gif
Authors' Report

Crónica del Autor
Print

Bibliographic references
Referencias bibliográficas

1. Krentz AJ, Patel MB, Bailey CJ. New drugs for type 2 diabetes mellitus: what is their place in therapy? Drugs. 2008;68(15):2131-2162.

2. Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL. Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am J Med. 1997;103(6):491-497.

3. Fujioka K, Pans M, Joyal S. Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation. Clin Ther. 2003;25(2):515-529.

4. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193-203.

5. Bailey CJ, Gross JL, Pieters A, Bastien A, List JF. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;375(9733):2223-2233.

Other articles written by the author James F. List
Otros artículos de James F. List





SIIC System of Assisted Editing (SSEA)
/ Sistema SIIC de Edición Asistida (SSEA)

James F. List was invited by SIIC on
James F. List fue invitado por SIIC el
2012, june 27
  The authors' report was accepted on
La crónica del autor fue aprobada el
2013, may 1
The authors' report was accepted on
La crónica del autor fue aprobada el
2013, may 1
Published in siicsalud
Publicado en siicsalud
2013, july 30





The article is strictly related to the following sections of siicsalud
El artículo se relaciona estrictamente con las siguientes secciones de siicsalud

 
Diabetology
/ Diabetología
 
Pharmacology
/ Farmacología
 

and secondarily related to the following sections

y secundariamente con las siguientes secciones

Health Care Management
Administración Hospitalaria

Primary Care
Atención Primaria

Diabetology in Adults
Diabetología en Adultos

Endocrinology and Metabolism
Endocrinología y Metabolismo

Clinical Pharmacology
Farmacología Clínica

Internal Medicine
Medicina Interna

Information about the full text
Acerca del trabajo completo


Dapaglifozin, Metformin XR, or Both: Initial Pharmacotherapy for Type 2 Diabetes, a Randomised Controlled Trial


Author / Autor
James F. List1, James F. List2

2 Vice President, Full Developme


Access to the original source
International Journal of Clinical Practice

Article URL:
/ URL del artículo:
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1742-1241

URL of Abstract:
/ URL del abstract:
http://www.ncbi.nlm.nih.gov/pubmed/22413962

URL of Abstract page in Medline:
/ URL del abstract en Medline:
http://www.ncbi.nlm.nih.gov/pubmed/22413962

URL of Abstract page in Scielo:
/ URL del abstract en Scielo:

URL of Abstract page in Scopus:
/ URL del abstract en Scopus:

URL of Abstract page in Embase:
/ URL del abstract en Embase:

Other data bases:
/ Otras bases de datos:

siic DB:
/ siic DB:
http://www.siicsalud.com/main/distriprinrel.php
ua32218
-->